Co-organized by Drs. Carla Saleh and Nevan Krogan, Institut Pasteur and the Quantitative Biosciences Institute present the "Institut Pasteur-Quantitative Biosciences Institute Mini Symposium on Emerging Infectious Diseases" in San Francisco on February 28, 2023.

The Quantitative Biosciences Institute (QBI) seeks transformative results in biomedicine by supporting fundamental quantitative research in the biological sciences. The Institut Pasteur thrives to increase its global health impact by strengthening fundamental biomedical research activities and their translation into biomedical innovations and technologies. The Quantitative Biology program of the Institut Pasteur intends to facilitate research innovation at the interface of infectious biology and quantitative sciences.

The 2023 IP-QBI Symposium aims to further collaborative relationships between scientists from both institutions. The Institut Pasteur and UCSF signed an official agreement to kick off a formal collaboration which will develop a joint Center on Emerging Infectious Diseases with QBI based in San Francisco. To strengthen the agreement and the collaborations among scientists, a small delegation of group leaders from the Institut Pasteur will be visiting from February 28th to March 2nd. Through this agreement, scientists will work together to identify opportunities to promote cooperative biosciences research and training activities.

Agenda

09:00 AM – Introductory remarks by Sam Hawgood, Mireille Guyader, Christophe D'Enfert, Nevan Krogan

09:25 AM – Olivier Schwartz, Institut Pasteur | "Multiplication and immune escape of SARS-COV-2 Omicron variants"

09:40 AM – Kliment Verba, QBI UCSF | "Leveraging structure, proteomics and rapid evolution to uncover functions of SARS CoV-2 Nsp2"

09:55 AM– Melanie Hamon, Institut Pasteur | "Bacteria targeting of host chromatin in health and disease"

10:10 AM – Melanie Ott, QBI UCSF/Gladstone Institutes | "Understanding SARS-CoV-2 attenuation through improved reverse genetics"

10:25 AM – Break

10:40 AM – Gerald Spaeth, Institut Pasteur | "Vector-borne parasites at Institut Pasteur: From neglected to emerging parasitoses"

10:55 AM – Shaeri Mukherjee, QBI UCSF | "Using pathogens as cell-biology tools"

11:10 AM – Caroline Demangel, Institut Pasteur | "Antivirals targeting the Sec61 translocon"

11:25 AM – George Scangos, Vir Biotechnology | "Antibodies in Pandemics"

11:40 AM – Closing Remarks by Carla Saleh